Analysis · Science
Why Ireland’s Pharmacy Vaccination Plan Took Months to Activate
By AWEI · AI-compiled · Published · Analysis prepared · 1 source · doi.org
Ireland’s community pharmacies appeared in the national COVID-19 vaccination plans published on 15 December 2020. They began delivering those vaccinations on 14 June 2021. Pharmacies already had years of flu vaccination experience, making the gap a revealing case of how an announced role becomes an operational service.
In their 2024 study, Aaron Koay and Camilla Devitt investigated this interval through a retrospective qualitative case study. They reviewed 246 documents, including records obtained through freedom of information requests, interviewed 11 people involved in policy, and received guidance from an 11-member stakeholder panel. Documents helped reconstruct the timeline; thematic analysis examined competing explanations.
One concrete bottleneck was information infrastructure. General practices had patient records for identifying priority groups and systems that could connect to the national vaccination database. Pharmacy systems lacked comparable integration. A pharmacy solution, PharmaVax, took months to develop. Vaccine scarcity, storage requirements, changing safety guidance and training requirements also featured in accounts of the delay.
Yet participants disagreed about whether these obstacles justified the timing. Some officials described a rational sequence under pressure. Pharmacy representatives questioned why similar operational concerns had not delayed general practices. Pharmacies also faced an expression-of-interest assessment that general practices did not. The authors interpreted these differences alongside pharmacy’s limited strategic representation and doctors’ stronger policy influence.
These are evidence-informed explanations, not experimentally established causes. Interviews occurred roughly 18 months after implementation, creating recall risks, and some key actors were not interviewed. Allegations of covert lobbying remained unsubstantiated. The study did not establish how much earlier pharmacy involvement would have changed vaccination coverage or health outcomes, and its Irish setting limits transfer elsewhere.
For readiness planning, the case suggests examining the dependencies behind each promised role: data connections, eligibility checks, approvals and representation in decisions. Those are concrete areas to assess before activation; this study does not quantify how much fixing them would shorten a future rollout.
Sources used for this article (1)
Direct links to the publisher reports used to prepare this article.
- Source 1
- What Obstructs Health Policy Implementation? A Multi-Method Qualitative Case Study of the Delayed Deployment of Community Pharmacies in Ireland’s National COVID-19 Vaccination Programme Aaron Koay, Camilla Devitt
